Log in to save to my catalogue

Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopan...

Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2797453500

Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis

About this item

Full title

Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis

Publisher

New York: Springer US

Journal title

Surgical endoscopy, 2023-04, Vol.37 (4), p.2698-2705

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Background
Endoscopic retrograde cholangiopancreatography (ERCP) is a popular technique; however, post-ERCP pancreatitis (PEP) remains a major adverse event. The administration of rectal nonsteroidal anti-inflammatory drugs (NSAIDs) is reportedly effective in preventing PEP. However, the recommended dose varies and the efficacy of low-dose recta...

Alternative Titles

Full title

Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2797453500

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2797453500

Other Identifiers

ISSN

0930-2794,1432-2218

E-ISSN

1432-2218

DOI

10.1007/s00464-022-09718-5

How to access this item